Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06236087 · ClinicalTrials.gov registry record
Overdose Prevention Centers and Behavioral Health
A clinical trial, sponsored by NYU Langone Health.
- Not yet
- Registry status
- 500
- Enrollment target
NCT06236087 is a clinical trial that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 500 participants.
The verdict
NCT06236087 has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- 500 participants
- Enrollment target
Study Summary
The aims of this study are: (Aim 1) Identify sources of heterogeneous impacts of opioid prevention center (OPC) use on non-fatal and fatal overdose risk among individuals with histories of polysubstance use (PSU); (Aim 2) Estimate the impact of OPC use on treated psychiatric events among clients with histories of PSU, and; (Aim 3) Assess the barriers and facilitators of integrating mental health services into existing syringe service and OPC delivery models.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2027-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06236087
The ClinicalTrials.gov registry entry for NCT06236087 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06236087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06236087 about?
NCT06236087 is a clinical study titled "Overdose Prevention Centers and Behavioral Health". The aims of this study are: (Aim 1) Identify sources of heterogeneous impacts of opioid prevention center (OPC) use on non-fatal and fatal overdose risk among individuals with histories of polysubstance use (PSU); (Aim 2) Estimate the impact of OPC use on treated psychiatric events among clients wit...
What is the current status of trial NCT06236087?
This trial is currently not yet recruiting. The enrollment target is 500 participants. The study started on 2026-09-01. Estimated completion is 2027-09-30.
Who is sponsoring clinical trial NCT06236087?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.